by doc | May 1, 2026 | Opioid Crisis
Heroin relapse rates range from 40 to 60 percent within the first year of recovery, but these numbers reflect the chronic nature of opioid use disorder rather than personal failure. Evidence-based relapse prevention combines medication-assisted treatment,...
by doc | May 1, 2026 | Opioid Crisis
The opioid epidemic claims approximately 80,000 lives annually from overdose in the United States alone, while Southeast Asia faces a parallel crisis driven by synthetic opioids flooding the Golden Triangle corridor. Thailand occupies a unique position as both a...
by doc | Apr 30, 2026 | Opioid Crisis
The pathway from prescription opioid use to heroin and illicit fentanyl is one of the most well-documented trajectories in addiction medicine. According to NIDA, approximately 80% of people who use heroin first misused prescription opioids, and 4 to 6% of people who...
by doc | Apr 30, 2026 | Opioid Crisis
The brain can and does heal after opioid addiction, but recovery is a process measured in months and years rather than days. Chronic opioid use causes measurable changes in brain structure and function, including mu-opioid receptor downregulation, disrupted dopamine...
by doc | Apr 30, 2026 | Opioid Crisis
Kratom (Mitragyna speciosa) is a tropical tree from Southeast Asia whose leaves contain mitragynine and 7-hydroxymitragynine, alkaloids that act on mu-opioid receptors in the brain. At low doses, kratom produces stimulant-like effects; at higher doses, it produces...
by doc | Apr 30, 2026 | Opioid Crisis
Naloxone (brand names Narcan and Kloxxado) is an opioid antagonist that rapidly reverses opioid overdose by competitively displacing opioids from mu-opioid receptors in the brain and brainstem. It restores breathing within two to five minutes when administered as a...